AlphAIAlphAI — Financial news for AI agents
investing.comOCT 221 min read$CME

JPMorgan upgrades CME Group stock rating on rates outlook

JPMorgan upgraded CME Group (CME) from Underweight to Overweight, raising its price target to $367. The firm cited a supportive interest rate environment, higher trading velocity, and market uncertainty as favorable for CME. The stock currently trades at $295.79. CME reported stronger-than-expected Q3 2026 results, with adjusted EPS of $3.02 and revenue of $1.74 billion, up 13% YoY.

Original reporting
investing.com
Published Oct 22, 2026, 11:04 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 11:43 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$CME
Bullish
high confidence
Mentioned
$CME
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CMEBullishHigh
01

Why it matters

The upgrade could attract new buying interest and lift CME's valuation relative to peers.

02

Market read

Analyst upgrade with a higher target is a fresh catalyst that may move CME's stock in the short term.

03

What to watch

Potential regulatory changes to derivatives markets could temper the bullish case.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

JPMorgan's research team highlighted a supportive interest‑rate environment and increased FX activity for CME.

Company-level read

Ticker impact

$CMEBullishHigh confidence
Context

JPMorgan upgraded CME Group to Overweight and raised its price target to $367, indicating a bullish view.

Expected impact

likely upward pressure as investors price in the new target

Evidence & confidence

The upgrade is a fresh, primary disclosure with a concrete target increase, providing a clear actionable signal.

Market effects

Sector

Positive outlook for exchange operators and market‑data providers as higher rates boost trading volume.

Regional

U.S. equities may see modest buying in financial services.

Global

Limited to markets tracking U.S. exchange stocks.

Counterpoint

What could challenge this read

Some investors may view the higher target as already priced in, limiting upside.

Key entities

  • company
    CME Group

    U.S. exchange operator providing futures and market‑data services.

  • financial_institution
    JPMorgan

    Analyst firm issuing the upgrade.

Read at source← All news

Related articles

OCT 22
$CMEMed

CME Maintained by Barclays -- Price Target Raised to $321

Barclays maintained an Equal-Weight rating on CME Group (CME) but raised its price target to $321 from $281. CME's stock is currently priced at $305.65, which is 10.8% overvalued according to its GF Value™ of $275.98. The company has a GF Score™ of 88/100, indicating strong performance in profitability and growth. 19 gurus hold CME, with 12 adding to their positions recently.

gurufocus.com2 min
OCT 22
$CMEMed

CME Maintained by Wells Fargo -- Price Target Raised to $333

Wells Fargo maintained an Overweight rating for CME Group and raised its price target to $333 from $315. CME operates the world's largest derivatives marketplace. GuruFocus values CME at $275.98, indicating a 10.9% overvaluation at its current price of $306.07. The company has a GF Score of 88, with strong growth and profitability metrics.

gurufocus.com2 min
OCT 21
$CMEMed

CME Group Inc (CME) (Q3 2026) Earnings Call Highlights: Record Volumes and Revenue

CME Group reported record Q3 2026 results, with $100 billion in daily margin savings driven by increased activity across asset classes. Market data business grew 20%, with diverse demand sources. CEO Terry Duffy discussed legal and strategic updates, including the CFTC perpetuals lawsuit and 24/7 trading plans. New products like single stock futures and TreasuryLink saw strong adoption. CME emphasized disciplined capital allocation and pricing adjustments.

finance.yahoo.com3 min
OCT 21
$CMEMed

CME Posts Record Q3 Revenue Despite Lower Daily Trading Volume

CME Group reported record Q3 revenue of $1.737bn, up 1.8% from Q2, despite a 1.3% drop in average daily volume. The increase was driven by two extra trading days and higher data service revenue. Clearing fees rose 1.9% to $1.378bn. CME launched new contracts but their impact on revenue is unclear. Fee changes in October could add 0.5%–1% to annual revenue.

financemagnates.com2 min